Bayer
Preço: 10.44Empresa e modelo de negócios
Bayer AG is a global healthcare and life sciences company that operates in pharmaceuticals, consumer health, crop science, and animal health. Its core products include prescription medications, over-the-counter products, agricultural solutions, and veterinary products. Major business segments are Pharmaceuticals, Consumer Health, Crop Science, and Animal Health, with revenue primarily derived from pharmaceutical sales and crop protection products.
Perfil de investimento
The investment profile of Bayer is more aligned with value investors due to its current low stock price relative to earnings and modest dividend yield. The company faces significant risks, which may deter growth-focused investors. The stock may appeal to those seeking stability and potential recovery over time rather than immediate gains.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- -0.53 Risco
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 20.3% ↑
- Surpresa de EPS
- 23.4% melhor que o esperado
- Volatilidade 20d
- 1.8% estável
- Dividend yield
- 0.3% baixo última data ex-dividendo: 2026-04-28
Acompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-05-30 02:31 | Manter | Vender | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-22 02:37 | Vender | Manter | Weak fundamentals and mixed momentum signal caution. |
| 2026-05-08 15:33 | — | Vender | Weak fundamentals and negative momentum signal high risk. |
Nada ainda